187 related articles for article (PubMed ID: 34627166)
1. Methods for the inclusion of real-world evidence in network meta-analysis.
Jenkins DA; Hussein H; Martina R; Dequen-O'Byrne P; Abrams KR; Bujkiewicz S
BMC Med Res Methodol; 2021 Oct; 21(1):207. PubMed ID: 34627166
[TBL] [Abstract][Full Text] [Related]
2. Methods for the Inclusion of Real-World Evidence in a Rare Events Meta-Analysis of Randomized Controlled Trials.
Yao M; Wang Y; Mei F; Zou K; Li L; Sun X
J Clin Med; 2023 Feb; 12(4):. PubMed ID: 36836227
[TBL] [Abstract][Full Text] [Related]
3. Hierarchical network meta-analysis models for synthesis of evidence from randomised and non-randomised studies.
Hussein H; Abrams KR; Gray LJ; Anwer S; Dias S; Bujkiewicz S
BMC Med Res Methodol; 2023 Apr; 23(1):97. PubMed ID: 37087450
[TBL] [Abstract][Full Text] [Related]
4. The inclusion of real world evidence in clinical development planning.
Martina R; Jenkins D; Bujkiewicz S; Dequen P; Abrams K;
Trials; 2018 Aug; 19(1):468. PubMed ID: 30157904
[TBL] [Abstract][Full Text] [Related]
5. Understanding the challenge of comparative effectiveness research in focal epilepsy: A review of network meta-analyses and real-world evidence on antiepileptic drugs.
Thieffry S; Klein P; Baulac M; Plumb J; Pelgrims B; Steeves S; Borghs S
Epilepsia; 2020 Apr; 61(4):595-609. PubMed ID: 32201951
[TBL] [Abstract][Full Text] [Related]
6. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
7. Meta-analyses using real-world data to generate clinical and epidemiological evidence: a systematic literature review of existing recommendations.
Briere JB; Bowrin K; Taieb V; Millier A; Toumi M; Coleman C
Curr Med Res Opin; 2018 Dec; 34(12):2125-2130. PubMed ID: 30217138
[TBL] [Abstract][Full Text] [Related]
8. Comparison of statistical methods for integrating real-world evidence in a rare events meta-analysis of randomized controlled trials.
Yao M; Wang Y; Ren Y; Jia Y; Zou K; Li L; Sun X
Res Synth Methods; 2023 Sep; 14(5):689-706. PubMed ID: 37309821
[TBL] [Abstract][Full Text] [Related]
9. Interventions for treating people with symptoms of bladder pain syndrome: a network meta-analysis.
Imamura M; Scott NW; Wallace SA; Ogah JA; Ford AA; Dubos YA; Brazzelli M
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013325. PubMed ID: 32734597
[TBL] [Abstract][Full Text] [Related]
10. Using Bayesian Evidence Synthesis Methods to Incorporate Real-World Evidence in Surrogate Endpoint Evaluation.
Wheaton L; Papanikos A; Thomas A; Bujkiewicz S
Med Decis Making; 2023 Jul; 43(5):539-552. PubMed ID: 36998240
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis.
Filippini G; Del Giovane C; Vacchi L; D'Amico R; Di Pietrantonj C; Beecher D; Salanti G
Cochrane Database Syst Rev; 2013 Jun; (6):CD008933. PubMed ID: 23744561
[TBL] [Abstract][Full Text] [Related]
12. Systematic literature review and network meta-analysis in highly active relapsing-remitting multiple sclerosis and rapidly evolving severe multiple sclerosis.
Huisman E; Papadimitropoulou K; Jarrett J; Bending M; Firth Z; Allen F; Adlard N
BMJ Open; 2017 Mar; 7(3):e013430. PubMed ID: 28283486
[TBL] [Abstract][Full Text] [Related]
13. Use of real-world evidence in meta-analyses and cost-effectiveness models.
Bowrin K; Briere JB; Levy P; Toumi M; Millier A
J Med Econ; 2020 Oct; 23(10):1053-1060. PubMed ID: 32657189
[TBL] [Abstract][Full Text] [Related]
14. Comparing the use of aggregate data and various methods of integrating individual patient data to network meta-analysis and its application to first-line ART.
Kanters S; Karim ME; Thorlund K; Anis AH; Zoratti M; Bansback N
BMC Med Res Methodol; 2021 Mar; 21(1):60. PubMed ID: 33784981
[TBL] [Abstract][Full Text] [Related]
15. Handling related publications reporting real-world evidence in network meta-analysis: a case study in multiple sclerosis.
Betts M; Fahrbach K; Neupane B; Slim M; Sormani MP; Cutter G; Debray TP; Rock M
J Comp Eff Res; 2023 Aug; 12(8):e220132. PubMed ID: 37515491
[No Abstract] [Full Text] [Related]
16. Emulating Randomized Clinical Trials With Nonrandomized Real-World Evidence Studies: First Results From the RCT DUPLICATE Initiative.
Franklin JM; Patorno E; Desai RJ; Glynn RJ; Martin D; Quinto K; Pawar A; Bessette LG; Lee H; Garry EM; Gautam N; Schneeweiss S
Circulation; 2021 Mar; 143(10):1002-1013. PubMed ID: 33327727
[TBL] [Abstract][Full Text] [Related]
17. The effect of adding real-world evidence to regulatory submissions on the breadth of population indicated for rare disease medicine treatment by the European Medicines Agency.
Jandhyala R
J Pharm Policy Pract; 2022 May; 15(1):36. PubMed ID: 35509059
[TBL] [Abstract][Full Text] [Related]
18. Synthesizing cross-design evidence and cross-format data using network meta-regression.
Hamza T; Chalkou K; Pellegrini F; Kuhle J; Benkert P; Lorscheider J; Zecca C; Iglesias-Urrutia CP; Manca A; Furukawa TA; Cipriani A; Salanti G
Res Synth Methods; 2023 Mar; 14(2):283-300. PubMed ID: 36625736
[TBL] [Abstract][Full Text] [Related]
19. The Case for Real-world Evidence in the Future of Clinical Research on Chronic Myeloid Leukemia.
Webster J; Smith BD
Clin Ther; 2019 Feb; 41(2):336-349. PubMed ID: 30709609
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
